Showing results (291-300 of 312) with videos related to

Sort By:
Pageof 32
Molecular Cancer Research : MCR|October 26, 2018
Frequent ESR1 and CDK Pathway Copy-Number Alterations in Metastatic Breast CancerAhmed Basudan, Nolan Priedigkeit, Ryan J Hartmaier, et al.
Targeted Oncology|October 5, 2024
Single-Hit and Multi-hit PIK3CA Short Variant Genomic Alterations in Clinically Advanced Prostate Cancer: A Genomic Landscape StudyMichael F Basin, Carla M Miguel, Joseph M Jacob, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 14, 2024
Characterizing the Genomic Landscape of the Micropapillary Subtype of Urothelial Carcinoma of the Bladder Harboring Activating Extracellular Mutations of ERBB2Jessica M Posada, Evgeny Yakirevich, Ashish M Kamat, et al.
Cancer Discovery|September 23, 2025
EML4-ALK Variant-Specific Genetic Interactions Shape Lung TumorigenesisAlberto Diaz-Jimenez, Emily G Shuldiner, Kalman Somogyi, et al.
NPJ Breast Cancer|July 3, 2019
FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtypeKevin M Levine, Nolan Priedigkeit, Ahmed Basudan, et al.
Cancer Discovery|October 31, 2020
Somatic HLA Class I Loss Is a Widespread Mechanism of Immune Evasion Which Refines the Use of Tumor Mutational Burden as a Biomarker of Checkpoint Inhibitor ResponseMeagan Montesion, Karthikeyan Murugesan, Dexter X Jin, et al.
JCO Precision Oncology|July 9, 2025
LODESTAR: A Single-Arm Phase II Study of Rucaparib in Solid Tumors With Pathogenic Germline or Somatic Variants in Homologous Recombination Repair GenesSriram Anbil, Nicholas J Seewald, E Gabriela Chiorean, et al.
Cancer|August 11, 2021
Contrasting genomic profiles from metastatic sites, primary tumors, and liquid biopsies of advanced prostate cancerAndrea Necchi, Vito Cucchiara, Petros Grivas, et al.
The Oncologist|March 11, 2022
Homologous Recombination Deficiency: Concepts, Definitions, and AssaysMark D Stewart, Diana Merino Vega, Rebecca C Arend, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 29, 2020
Pan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1-KMT2A-YAP1 and VIM-KMT2A fusionsLucas R Massoth, Yin P Hung, Valentina Nardi, et al.
Pageof 32